Most patients with these problems—which can lead to permanent disability and death—developed symptoms within a day of receiving an initial infusion of Lemtrada, the agency said. In one patient, symptoms occurred three days after receiving the drug. (HealthDay)—A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears...
Tag: <span>Alemtuzumab</span>
Post
Previously unpublished trial data explain effects and side effects of key MS drug
Alemtuzumab is a highly effective drug for multiple sclerosis, approved in more than 60 countries and used by more than 12,000 patients worldwide. However, there is an almost 50 per cent risk of secondary autoimmune diseases, some of which are life-threatening, such as platelet and kidney diseases. Although knowledge about these adverse effects was included...